Kohei Kobatake

1 Patent

• US125839182026

  Therapeutic Agent for Urological Cancer Which Is Characterized by Being Administered with IL-6 Inhibitor and CCR2 Inhibitor in Combination

  Chugai Seiyaku Kabushiki Kaisha

  0 cites